✦ LIBER ✦

Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

✍ Scribed by K.Y. LOOK; J.A. BLESSING; C.M. MICHENER; S.C. RUBIN; P.T. RAMIREZ

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of tamoxifen in persistent or

✍ L. R. Bigler; J. Tate Thigpen; J. A. Blessing; J. Fiorica; B. J. Monk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Topotecan in Squamous Cell Carcinoma of

✍ Michael A. Bookman; John A. Blessing; Parviz Hanjani; Thomas J. Herzog; Willie A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Evaluation of Gemcitabine in Patients wi

✍ Russell J. Schilder; John A. Blessing; Mark Morgan; Charles E. Mangan; Janet S. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A Phase II Study of Topotecan in Patient

✍ Laila I. Muderspach; John A. Blessing; Charles Levenback; James L. Moore Jr.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A phase II trial of pyrazoloacridine (PZ

✍ Steven C. Plaxe; John A. Blessing; George Olt; Nader Husseinzadah; Samuel S. Len 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 71 KB

A Phase II Trial of Pyrazoloacridine (PZ

✍ Steven C. Plaxe; John A. Blessing; Joseph A. Lucci; Jean A. Hurteau 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 40 KB